• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Endocrinology

Type 2 diabetes associated with reduction in disability-free life years

byDeepti ShroffandDavid Wang
January 16, 2016
in Endocrinology, Public Health
Reading Time: 2 mins read
Type 2 diabetes associated with reduction in disability-free life years
Share on FacebookShare on Twitter

1. In a retrospective review of over 20 000 adults over the age of 50, adults with type 2 diabetes (T2DM) experienced a significant reduction in total and disability-free life-years compared to adults without T2DM.

Evidence Rating Level: 3 (Average)

Study Rundown: There has been a significant increase in the number of years that an average person lives with T2DM due to the increasing life expectancy in diabetic patients. However, there is limited data on estimates of disability-free years lost to T2DM. The objective of this large cohort study was to quantify the impact of diabetes on the state of disability and longevity in a population of adults in the United States.

The study analyzed self-reported data from over 20 000 adults over the age of 50 as part of a prospective, biannual survey from 1998 to 2012. Specifically, adults with T2DM developed disabilities approximately 6 years earlier and experienced an average of 1 to 2 years more in a disabled state. This effect was seen in both men and women in this cohort. The results of this study . The strength of the study is the large sample size, which provided a representative cohort of the United States population and improves external generalizability. The study was limited by the use of self-reported data, which may introduce recall bias in both incidences of T2DM and disability.

Click to read the study in Diabetes Care

Relevant Reading: Association of functional decline with subsequent diabetes incidence in U.S. adults aged 51 years and older: the Health and Retirement Study 1998-2010

RELATED REPORTS

2 Minute Medicine Rewind August 31, 2026

Swedish study reports low vision loss risk with GLP-1RAs

GLP-1RAs may increase ischemic optic neuropathy risk

In-Depth [retrospective cohort]: Patient data from the Health and Retirement Study, a prospectively-collected, population-based health survey in the United States were reviewed. The main outcomes investigated were self-reported rates of T2DM and disability, defined as loss of mobility, difficulty performing daily activities, and/or difficulty performing instrumental daily activities. A health state transition simulation model was used to compare the disability outcomes of participants with and without diabetes. A total of 20 008 adults over the age of 50 were followed from 1998 to 2012. At the conclusion of the study, patients with T2DM demonstrated a significant reduction in total disability-free years compared to the non-T2DM population. Overall, starting at age 50 years, the cohort diagnosed with T2DM died 4.6 years earlier and developed disability 6 to 7 years earlier than those in the non-T2DM cohort. The association between T2DM and decreased disability-free life years were significant in subgroup analyses among both men and women.

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: Type 2 Diabetes Mellitus
Previous Post

Pre-exposure prophylaxis may reduce HIV in the UK MSM population

Next Post

Attempting to conceive within 3 months of pregnancy loss associated with greater success

RelatedReports

Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source
Weekly Rewinds

2 Minute Medicine Rewind August 31, 2026

August 31, 2026
Type 2 diabetes associated with reduction in disability-free life years
Endocrinology

Swedish study reports low vision loss risk with GLP-1RAs

July 13, 2026
Intrapartum serum prolactin may predict risk of postpartum diabetes
Endocrinology

GLP-1RAs may increase ischemic optic neuropathy risk

July 13, 2026
Endocrinology

GLP-1RAs showed no advantage for basal insulin discontinuation

July 13, 2026
Next Post
Late gestation antidepressant use linked to postpartum hemorrhage

Attempting to conceive within 3 months of pregnancy loss associated with greater success

Reduced gestational weight gain with lifestyle intervention

Reduced gestational weight gain with lifestyle intervention

Few high school students, young adults get HIV testing

Few high school students, young adults get HIV testing

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • An ultrasound-guided percutaneous method of vagal nerve stimulation may be effective for refractory chronic pain
  • Daraxonrasib extends survival in metastatic pancreatic cancer
  • Artificial intelligence (AI) scribes showed mixed effects on documentation time and improvements in physician well-being
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.